Humasis Co. Ltd. (KOSDAQ:205470)
South Korea
· Delayed Price · Currency is KRW 1,181.00
+4.00 (0.34%)
At close: Dec 5, 2025
Humasis Revenue
Humasis had revenue of 8.65B KRW in the quarter ending September 30, 2025, a decrease of -17.91%. This brings the company's revenue in the last twelve months to 35.60B, up 114.87% year-over-year. In the year 2024, Humasis had annual revenue of 25.41B with 83.79% growth.
Revenue (ttm)
35.60B
Revenue Growth
+114.87%
P/S Ratio
3.75
Revenue / Employee
515.97M
Employees
69
Market Cap
133.63B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |